FIELD: medicine.
SUBSTANCE: invention refers to medicine, namely to ophthalmology and is intended for prediction of unfavorable course of initial choroid melanoma after organ-preserving treatment. Level of transforming growth factor TGF-β2 is determined in blood serum before organ preservation treatment. If it is more than 5,000 pcg/ml, unfavorable course is predicted.
EFFECT: method enables selecting a timely, adequate treatment of initial choroid melanoma after an organ-preserving intervention.
1 cl, 5 ex
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD FOR DETECTING AN INFLAMMATORY COMPONENT THAT PROMOTES TUMOR GROWTH IN INITIAL CHOROIDAL MELANOMA | 2020 |
|
RU2748528C1 |
| METHOD FOR THE DIFFERENTIAL DIAGNOSIS OF MELANOMA OF THE CHOROID OF THE CENTRAL LOCALIZATION AND THE LATE STAGE OF AGE-RELATED MACULAR DEGENERATION | 2022 |
|
RU2792554C1 |
| METHOD FOR PREDICTION OF UNFAVOURABLE COURSE OF UVEAL MELANOMA | 2018 |
|
RU2698797C1 |
| METHOD FOR PREDICTING THE SURVIVAL CAPACITY OF PATIENTS AFTER ENUCLEATION FOR INITIAL CHOROID MELANOMA SPREAD TO THE OPTIC DISC | 2021 |
|
RU2778965C1 |
| METHOD FOR PREDICTING THE UNFAVORABLE COURSE OF UVEAL MELANOMA ASSOCIATED WITH A MALIGNANT MICROENVIRONMENT | 2019 |
|
RU2709214C1 |
| METHOD FOR PREDICTING THE COURSE OF THE INITIAL CHOROIDAL MELANOMA | 2017 |
|
RU2645644C1 |
| METHOD FOR PREDICTION OF SEVERE UVEAL MELANOMA | 2019 |
|
RU2705417C1 |
| METHOD OF COMBINED ONE-STAGE LASER TREATMENT OF SMALL-SIZED AMELANOTIC CHOROIDAL MELANOMA OF JUXTAPIPILLARY LOCALIZATION | 2023 |
|
RU2805827C1 |
| METHOD FOR DETERMINING INDICATIONS FOR THE REPEATED DESTRUCTION OF THE INITIAL MELANOMA OF CHOROID | 2017 |
|
RU2665185C1 |
| METHOD FOR DIFFERENTIAL DIAGNOSIS OF INITIAL CHOROID MELANOMA AND CHOROID NEVUS BY MEANS OF OPTICAL COHERENT TOMOGRAPHY WITH ANGIOGRAPHIC MODE | 2019 |
|
RU2705419C1 |
